Over the last 12 months, Clearmind Medicine insiders reported 1 buy totaling $330K and 4 sales totaling $119K across SEC Form 4 filings.
| Date | Insider | Type | Shares | Avg price | Value | Δ stake | Marks |
|---|---|---|---|---|---|---|---|
| Jun 16, 2026 | HRT FINANCIAL LP10% | ▼ Sale | 22,139 | $3.31 | $73K | -21.4% | — |
| Jun 15, 2026 | HRT FINANCIAL LP10% | ▼ Sale | 3,183 | $3.32 | $11K | -3% | — |
| Jun 12, 2026 | HRT FINANCIAL LP10% | ▼ Sale | 2,102 | $3.36 | $7K | -1.9% | — |
| Jun 11, 2026 | HRT FINANCIAL LP10% | ▼ Sale | 225,191 | $0.12 | $28K | -10.9% | — |
| Jun 10, 2026 | HRT FINANCIAL LP10% | ▲ Buy | 2,159,052 | $0.15 | $330K | — | — |
Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $CMND feed.